14.08.2019 • NewsPeopleSchirm

Schirm Announces Two Senior Leadership Appointments

Schirm USA, a subsidiary of Schirm in Germany, has appointed Chad Kern (48) as chief executive officer (CEO), effective Aug. 1, 2019. He succeeds Gus Jones, who will retire in September.

Kern holds a BS in agriculture from Southern Illinois University and has worked in the chemical industry for 20 years. He joined Schirm more than 11 years ago and held various positions in purchasing, EH&S, as lead engineer and facility construction manager. In his most recent role he served as director of manufacturing.

In a separate news, Schönebeck, Germany-headquartered Schirm announced the appointment of Trevor Roberts (43) as chief operating officer (COO), effective Jul. 3, 2019.

In his position, Roberts will support the management team of Dirk Unterstenhöfer (CEO) and Alfred Ludorf (CFO) in the operating business and also take over the complete responsibility for all four Schirm business locations in Germany.

Before joining Schirm, Roberts held various management positions at Schirm’s parent company, the South African AECI Group, most recently as chief procurement officer.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.